Nasdaq Most Active

Vanda Pharmaceuticals Inc.

Ticker: VNDA
Current Price: $3.99
% Daily Change: 1.01%
Volume (1,000s): 823.28
Average Volume (1,000s): 1,003.04
Market Cap (M): $241.27
1/2/2024 Price: $4.52
Change Since Inception: -11.73%
Updated at 9:50:03 AM EST
See full index: PRISM Mental Health
Contact Information

Vanda Pharmaceuticals Inc.
2200 Pennsylvania Avenue NW
Suite 300E
Washington, DC 20037
United States

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals is a biopharmaceutical company that develops and sells treatments for central nervous system disorders. The company’s goal is to improve patients’ lives by addressing unmet medical needs. Vanda’s products include:
  • Fanapt: An antipsychotic used to treat schizophrenia in adults
  • Hetlioz: A melatonin receptor agonist used to treat non-24-hour sleep-wake disorder and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS)
Vanda’s other products include Tradipitant (VLY-686), VTR-297, VQW-765, and CFTR, which are part of a portfolio of cystic fibrosis transmembrane conductance regulator inhibitors and activators. The company’s CEO, Mihales Polymeropoulos, MD, founded Vanda in 2003 with Care Capital LLC and Bio*One Capital. Vanda is headquartered in Washington, DC

Market Data

News

Next Up

November 13, 2026
Cerenome, Inc.
November 09, 2026
Vir Biotechnology, Inc.
November 03, 2026
SI-BONE, Inc.

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup